Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1040 | 1040 | 1089 | 1266 | 1339 | 1798 |
Fund Return | 4.01% | 4.01% | 8.87% | 8.19% | 6.02% | 6.04% |
Place in category | 161 | 161 | 143 | 138 | 55 | 50 |
% in Category | 20 | 20 | 21 | 30 | 12 | 14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPM US Equity Income Fund B Net Acc | 3.55B | 7.67 | 9.61 | 12.16 | ||
JPM US Equity Income Fund B Net Inc | 3.55B | 7.67 | 9.60 | 12.16 | ||
JPM US Equity Income Fund C Net Acc | 3.55B | 7.75 | 9.99 | 12.52 | ||
JPM US Equity Income Fund C Net Inc | 3.55B | 7.76 | 9.99 | 12.52 | ||
JPM US Equity Income Fund X Net Acc | 3.55B | 3.29 | 11.72 | 13.15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 13.79B | 4.02 | 7.99 | 5.79 | ||
All Share Index Unit Trust Income | 13.79B | -0.70 | 7.89 | - | ||
VG UK Plus GBP Accumulation | 13.79B | -0.70 | 7.91 | - | ||
VG UK Institutional Plus GBP Income | 13.79B | -0.69 | 7.90 | - | ||
UK Equity Tracker Fund D Acc | 11.33B | 2.82 | 7.88 | 5.79 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 7.24 | 34.05 | +0.01% | |
AstraZeneca | GB0009895292 | 6.58 | 11,988.0 | -0.32% | |
HSBC | GB0005405286 | 5.34 | 663.60 | +0.26% | |
Unilever | GB00B10RZP78 | 3.73 | 48.25 | +1.39% | |
BP | GB0007980591 | 3.62 | 524.80 | -0.28% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review